Burden of Congenital CMV Infection: A Narrative Review and Implications for Public Health Interventions

Cecilia Liberati1, Giulia Sturniolo1, Giulia Brigadoi1

  • 1Department of Women's and Children's Health, Pediatric Infectious Disease, Padua University Hospital, 35126 Padua, Italy.

Viruses
|August 29, 2024
PubMed

Insights

Congenital Cytomegalovirus (CMV) is a common global infection. This review explores screening, treatment, and vaccines to reduce the burden of congenital CMV and its potential infant health impacts.

Area of Science:

  • * Infectious Diseases
  • * Public Health
  • * Pediatrics

Background:

  • * Congenital Cytomegalovirus (CMV) is the most prevalent congenital infection globally.
  • * Most infected infants are asymptomatic at birth, but some develop severe health issues like hearing loss or neurological impairment.
  • * Public health interventions are crucial for mitigating the impact of congenital CMV.

Purpose of the Study:

  • * To review maternal and neonatal screening programs for congenital Cytomegalovirus.
  • * To assess current evidence regarding treatment and vaccine development for CMV.
  • * To outline potential benefits and biases of public health interventions for congenital CMV.

Main Methods:

  • * Comprehensive literature review of studies on congenital Cytomegalovirus.
  • * Analysis of data on maternal and neonatal screening programs.
  • * Evaluation of evidence for CMV treatment and vaccine development.

Main Results:

  • * Congenital CMV infection presents a significant global health challenge with varied infant outcomes.
  • * Screening, treatment, and vaccine development are key areas for intervention.
  • * Evidence for the efficacy and optimal implementation of interventions requires ongoing evaluation.

Conclusions:

  • * Public health strategies, including screening, are essential to reduce the burden of congenital CMV.
  • * Further research into effective treatments and preventative vaccines is critical.
  • * Informed public health policy and debate require a thorough understanding of the evidence and potential intervention biases.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
926
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
146
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
286
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
295